CRISPR Democracy: Gene Editing and the Need for Inclusive Deliberation
By J. Benjamin Hurlbut, Krishanu Saha, & Sheila Jasanoff,
Issues in Science and Technology
| 09. 21. 2015
Not since the early, heady days of recombinant DNA (rDNA) has a technique of molecular biology so gripped the scientific imagination as the CRISPR-Cas9 method of gene editing. Its promises are similar to those of rDNA, which radically transformed the economic and social practices of biotechnology in the mid-1970s. Ivory tower rDNA science morphed into a multibillion dollar technological enterprise built on individual entrepreneurship, venture capital, start-ups, and wide-ranging university-industry collaborations. But gene editing seems even more immediate and exciting in its promises. If rDNA techniques rewrote the book of life, making entire genomes readable, then CRISPR applies an editorial eye to the resulting book, searching for typos and other infelicities that mar the basic text. Gene editing shows many signs of being cheaper, faster, more accurate, and more widely applicable than older rDNA techniques because of its ability to cut and alter the DNA of any species at almost any genomic site with ease and precision.
Since their development, gene editing techniques have been used for many purposes: improving bacterial strains used in dairy products, making new animals for...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...